Contributor
Jim Woodgett is senior investigator, Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
As designed, the CIHR's funding opportunities to study the emergence of COVID-19 Variants of Concern (VoCs) are unlikely to achieve actionable results in a timeframe that could save lives.